Mylan could be facing another issue when it comes to the EpiPen, a drug used to treat severe allergic reactions that …
Daniel Zuchnik—WireImage By Julia Zorthian August 25, 2016 Actress Sarah Jessica Parker is ending her relationship with pharmaceutical giant Mylan and speaking out against ... spoke against the price hike and its stock plummeted …
NEW YORK (CNNMoney.com) -- Mylan Pharmaceuticals' stock plunged after the drugmaker said it was purchasing the generic arm of German drug giant Merck KGaA. Mylan (down $2.49 to $19.91, Charts) stock fell more than 13 percent …
Teva Pharmaceutical Industries, Ltd., has been trying to buy fellow giant generic drugmaker Mylan, Inc., and the latest step to emerge was the purchase of chunks of stock on the open market. Teva said it had bought a 1.35% stake in Mylan at …
Shares of Mylan N.V.’s MYL were up 7.2% after the company beat expectations in the fourth-quarter 2016 and provided a strong outlook for 2017 amid challenging conditions. The company reported fourth-quarter 2016 earnings of $1.57 per …
Of the company's shareholders who voted, 98 percent approved the transaction. Yet not all stockholders were aware of the tax implications. John Kablach, 85, of Smithton only recently found out he would have to pay capital gains on his Mylan …
Mylan acquired rights for EpiPen ... Company shares jumped 14 percent at the opening bell. The stock has fallen 13 percent since the start of the year but is up …
Mylan's shares dropped after it said that delays in launching key new drugs and lower prices for generics in the United States will hurt its profitability this and next year. Fred Katayama reports.